Drug Type Chemical drugs |
Synonyms- |
Target |
Action inhibitors |
Mechanism RNF31 inhibitors(ring finger protein 31 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diffuse Large B-Cell Lymphoma | Preclinical | Spain | 18 Apr 2023 | |
Diffuse Large B-Cell Lymphoma | Preclinical | Spain | 18 Apr 2023 |